Search

Displaying results 8551 - 8560 of 10000 in total
  1. Drug

    Gavilimomab

    go.drugbank.com/drugs/DB06545
    Investigational

  2. Drug

    Nemonoxacin

    go.drugbank.com/drugs/DB06600
    Investigational

  3. Drug

    Fispemifene

    go.drugbank.com/drugs/DB06640
    Investigational

  4. Drug

    Priralfinamide

    go.drugbank.com/drugs/DB06649
    Investigational

  5. Drug

    Almorexant

    go.drugbank.com/drugs/DB06673
    Investigational

  6. Drug

    Naluzotan

    go.drugbank.com/drugs/DB05562
    Investigational

    Categories: Serotonin Receptor Agonists, Serotonin 5-HT1 Receptor Agonists
  7. Drug

    TC-2696

    go.drugbank.com/drugs/DB05576
    Experimental

  8. Drug

    Enibarcimab

    go.drugbank.com/drugs/DB16730
    Investigational

    Enibarcimab is under investigation in clinical trial NCT03989531 (Adrecizumab in Cardiogenic Shock).

  9. Drug

    Capadenoson

    go.drugbank.com/drugs/DB16118
    Investigational

    Capadenoson is under investigation in clinical trial NCT00518921 (Capadenoson in Angina Pectoris).

    Categories: Adenosine A receptor agonists, Adenosine A1 Receptor Agonists
  10. Drug

    WNY0824

    go.drugbank.com/drugs/DB23606
    Experimental

    [A274253] It is a dual inhibitor of PLK-1 and BRET-4, which have both been found to be involved in CRPC via suppression of AR/MYC-mediated transcription. [A274258] … WNY0824 is a preclinical small molecule drug being investigated for the treatment of Castration-Resistant Prostrate Cancer (CRPC).

    Synonyms: PLK1/BRD4-IN-1